Breast Cancer Surgery
81 – 90 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
(2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532
- Contribution to journal › Published meeting abstract
-
Mark
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
- Contribution to journal › Article
-
Mark
Barriers and facilitators for individualized rehabilitation during breast cancer treatment- A focus group study exploring health care professionals' experiences
- Contribution to journal › Article
-
Mark
The generalisability of randomised clinical trials : an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
- Contribution to journal › Article
-
Mark
Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment : Study protocol for the ReScreen randomized controlled trial
- Contribution to journal › Article
-
Mark
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
- Contribution to journal › Article
-
Mark
Cosmetic outcome and symmetry for patients who have undergone bilateral therapeutic mammoplasty for breast cancer
- Contribution to journal › Article
-
Mark
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer : data from a randomised trial with long-term follow-up
- Contribution to journal › Article
-
Mark
Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
- Contribution to journal › Published meeting abstract
-
Mark
Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions - A feasibility study
- Contribution to journal › Article
